FSI Stanford Events

The Cost-Effectiveness of Mass Screening to Detect Asymptomatic Heart Failure

CHP/PCOR Research in Progress Seminar

Date and Time
April 16, 2003
1:30 PM - 3:00 PM

Availability
Open to the public
No RSVP required

Speaker
Paul A. Heidenreich - Assistant Professor

Location
Health Research & Policy Building
(Redwood Building), Room T138-B
259 Campus Drive
Stanford University
Stanford, CA 94305
» Directions/Map

FSI Contact
Kathryn M. McDonald

Non-FSI Contact
Elaine Steel, 650-723-6426

Parent Research Projects

Cost-Effectiveness of Genetic Screening in Sudden Cardiac Death
Gillian D. Sanders
Improving the Quality of Heart Failure Care: Interventions to Increase Beta-Blockers Use
Paul A. Heidenreich
Screening for Hypothyroidism in Pregnancy: A Cost-effectiveness Analysis
Christy Dosiou, MD
Cost-Effectiveness Analyses: Cost-Effectiveness of Vaccinating College Freshmen against Meningitis
Gillian D. Sanders, P Bilir, C Rydzak

Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Individuals
Tina Lee, NA Solomon, Paul A. Heidenreich, J Oehlert, Alan M. Garber
Annals of Internal Medicine vol. 126 (1997)
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction
Paul A. Heidenreich, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG
Journal of the American College of Cardiology vol. 43, 6 (2004)
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C
OS Lin, EB Keeffe, GD Sanders, Douglas K. Owens
Alimentary Pharmacology & Therapeutics vol. 19, 11 (2004)
Cost-effectiveness of voluntary HIV screening in Russia
Swati Tole, AM Bayoumi, Cristina Galvin, TN Vinichenko, Margaret L. Brandeau, Douglas K. Owens
International Journal of STD and AIDS vol. 20, 1 (2009)